Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Renal Cell Carcinoma”

166 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 166 results

Early research (Phase 1)Ended earlyNCT00492440
What this trial is testing

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Cytheris SA 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04393350
What this trial is testing

Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Kidney CancerStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8
Emory University 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05363631
What this trial is testing

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Who this might be right for
Clear Cell Renal Cell CarcinomaClear Cell Renal Cell Carcinoma Metastatic
Mohammed Milhem 55
Early research (Phase 1)Active Not RecruitingNCT05653882
What this trial is testing

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerMelanoma+2 more
Asher Biotherapeutics, Inc. 552
Testing effectiveness (Phase 2)Study completedNCT01090466
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 15
Testing effectiveness (Phase 2)Study completedNCT01538238
What this trial is testing

Pazopanib_NCRCC,Ph2 STUDY

Who this might be right for
Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma
Samsung Medical Center 10
Not applicableStudy completedNCT01107509
What this trial is testing

Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers

Who this might be right for
Carcinoma, Renal Cell
St. Joseph's Healthcare Hamilton 20
Testing effectiveness (Phase 2)Ended earlyNCT00203866
What this trial is testing

Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Chicago 40
Very early researchLooking for participantsNCT06586658
What this trial is testing

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

Who this might be right for
Renal Cell Carcinoma
Shanghai Changzheng Hospital 9
Early research (Phase 1)Study completedNCT01625936
What this trial is testing

CRLX101 Plus Bevacizumab in Advanced RCC

Who this might be right for
Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03945773
What this trial is testing

Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors

Who this might be right for
Locally Advanced or Metastatic Renal Cell Carcinoma
Ipsen 127
Large-scale testing (Phase 3)Study completedNCT02853331
What this trial is testing

Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 861
Not applicableActive Not RecruitingNCT04922307
What this trial is testing

Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Vanderbilt University Medical Center 240
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)UnknownNCT04995016
What this trial is testing

Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Second Hospital 18
Large-scale testing (Phase 3)Study completedNCT01235962
What this trial is testing

Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma (RCC)Cancer
Novartis Pharmaceuticals 1,538
Testing effectiveness (Phase 2)Looking for participantsNCT05096390
What this trial is testing

Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC

Who this might be right for
Papillary Renal Cell Carcinoma Type 2
Centre Leon Berard 72
Testing effectiveness (Phase 2)UnknownNCT05877820
What this trial is testing

Evaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCC

Who this might be right for
Fumarate Hydratase Deficient Renal Cell Carcinoma
RenJi Hospital 10
Early research (Phase 1)Study completedNCT00588276
What this trial is testing

Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors

Who this might be right for
Cervical CancerHEENT CancerRenal Cancer+3 more
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)WithdrawnNCT03935347
What this trial is testing

Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial Carcinoma+3 more
Roswell Park Cancer Institute
Load More Results